SARS-CoV-2 outbreaks on Danish mink farms and mitigating public health interventions.


Journal

European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966

Informations de publication

Date de publication:
01 02 2022
Historique:
pubmed: 9 10 2021
medline: 5 2 2022
entrez: 8 10 2021
Statut: ppublish

Résumé

First severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on Danish mink farms were reported in June 2020 and thereupon spread geographically. We provide population-level evidence on excess human incidence rates in Danish municipalities affected by disease outbreaks on mink farms and evaluate the effectiveness of two non-pharmaceutical interventions, i.e. culling of infected mink and local lockdowns. We use information on SARS-CoV-2 outbreaks on mink farms in 94 Danish municipalities together with data on human SARS-CoV-2 cases and tested persons in Weeks 24-51 of 2020. Difference-in-difference estimation and panel event studies for weekly human incidence rates are applied to (i) identify epidemiological trends of human SARS-CoV-2 infections associated with disease outbreaks on mink farms, and (ii) quantify the mitigating effects from the two non-pharmaceutical interventions. SARS-CoV-2 outbreaks on mink farms in a municipality associate with an increase in weekly human incidence rates by about 75%; spatial spillover effects to neighbouring municipalities are also observed. Local lockdowns reduce human incidence rates, while culling of mink appears to be more effective in combination with a lockdown. The temporal lag between an outbreak on a mink farm and a significant increase in human incidence rates is estimated to be 1-3 weeks; lockdowns and culling of mink neutralize this effect 4-8 weeks after the initial outbreak. SARS-CoV-2 infections among farmed mink in Denmark significantly link to local human infection trends. Strict animal and human disease surveillance in regions with mink farming should be pursued internationally to mitigate future epidemic developments.

Sections du résumé

BACKGROUND
First severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on Danish mink farms were reported in June 2020 and thereupon spread geographically. We provide population-level evidence on excess human incidence rates in Danish municipalities affected by disease outbreaks on mink farms and evaluate the effectiveness of two non-pharmaceutical interventions, i.e. culling of infected mink and local lockdowns.
METHODS
We use information on SARS-CoV-2 outbreaks on mink farms in 94 Danish municipalities together with data on human SARS-CoV-2 cases and tested persons in Weeks 24-51 of 2020. Difference-in-difference estimation and panel event studies for weekly human incidence rates are applied to (i) identify epidemiological trends of human SARS-CoV-2 infections associated with disease outbreaks on mink farms, and (ii) quantify the mitigating effects from the two non-pharmaceutical interventions.
RESULTS
SARS-CoV-2 outbreaks on mink farms in a municipality associate with an increase in weekly human incidence rates by about 75%; spatial spillover effects to neighbouring municipalities are also observed. Local lockdowns reduce human incidence rates, while culling of mink appears to be more effective in combination with a lockdown. The temporal lag between an outbreak on a mink farm and a significant increase in human incidence rates is estimated to be 1-3 weeks; lockdowns and culling of mink neutralize this effect 4-8 weeks after the initial outbreak.
CONCLUSIONS
SARS-CoV-2 infections among farmed mink in Denmark significantly link to local human infection trends. Strict animal and human disease surveillance in regions with mink farming should be pursued internationally to mitigate future epidemic developments.

Identifiants

pubmed: 34623404
pii: 6384575
doi: 10.1093/eurpub/ckab182
pmc: PMC8549281
doi:

Banques de données

figshare
['10.6084/m9.figshare.14039666']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-157

Subventions

Organisme : Open-Access-Fund of the Helmut-Schmidt-University/ University of the Federal Armed Forces Hamburg

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Public Health Association.

Références

Science. 2021 Jan 8;371(6525):172-177
pubmed: 33172935
Science. 2003 Jun 20;300(5627):1961-6
pubmed: 12766206
Lancet. 2013 Aug 24;382(9893):662-4
pubmed: 23831143
Nat Commun. 2021 Feb 8;12(1):846
pubmed: 33558479
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Lancet Infect Dis. 2021 Jan;21(1):18-19
pubmed: 33227234
Emerg Infect Dis. 2021 Feb;27(2):547-551
pubmed: 33207152
Euro Surveill. 2021 Feb;26(5):
pubmed: 33541485
Annu Rev Public Health. 2018 Apr 1;39:453-469
pubmed: 29328877
Am J Trop Med Hyg. 2020 Sep;103(3):955-959
pubmed: 32700664
J Reg Sci. 2021 Jun 20;:
pubmed: 34230689
Lancet Infect Dis. 2020 Oct;20(10):1151-1160
pubmed: 32559451
Lancet Public Health. 2020 Nov;5(11):e612-e623
pubmed: 33065023
Euro Surveill. 2020 Jun;25(23):
pubmed: 32553059
Animals (Basel). 2021 Jan 12;11(1):
pubmed: 33445704
J Virol. 2010 Jan;84(1):21-6
pubmed: 19828604
Eur J Public Health. 2020 Dec 11;30(6):1176-1180
pubmed: 32818263

Auteurs

Torben Dall Schmidt (T)

Institute of Employment Relations and Labour (IPA), Helmut Schmidt University, Hamburg, Germany.
Department of Business and Economics, University of Southern Denmark, Odense, Denmark.

Timo Mitze (T)

Department of Business and Economics, University of Southern Denmark, Odense, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH